PRELUDE THERAPEUTICS INC (PRLD) Operating income 2019–2025
PRELUDE THERAPEUTICS INC (PRLD) annual operating income history from SEC filings — each fiscal year as reported.
-$104.6MFY2025 · since FY2019: -$28.1M → -$104.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$104.6M | +25.2% |
| FY2024 | -$139.7M | -5.6% |
| FY2023 | -$132.3M | -7.1% |
| FY2022 | -$123.5M | -8.6% |
| FY2021 | -$113.7M | -93.5% |
| FY2020 | -$58.8M | -109.1% |
| FY2019 | -$28.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice